What you'll learn in this expert session
As of 1 November 2023, new Medicare rebates are available for "essential carrier screening tests", such as cystic fibrosis, spinal muscular atrophy, fragile X, for women planning pregnancy, who are already pregnant and their partners. However, other tests may also be required based on the patient's specific needs and risk profile. In this presentation, Dr Rashi Kalra will explain the benefits of these tests, their application, who they are most relevant to, whether or not extra tests might be needed and how best to explain them to your patients.
About the Expert
Dr Rashi Kalra
Dr Kalra is part of a select group of doctors in Melbourne to obtain the highest level of postgraduate qualification as a fertility subspecialist, CREI (certificate in reproductive endocrinology and infertility). She uses her knowledge, experience and passion for fertility medicine to help her patients achieve the best outcomes possible.
Dr Kalra has worked in two of Australia’s leading fertility units, including the Royal Women’s Hospital, Melbourne and draws on this experience to provide her patients with up-to-date and evidence-based care. She is passionate about offering appropriate advice, investigation and treatment to her patients. Where less invasive fertility treatments are indicated such as lifestyle changes and ovulation induction, she is a strong advocate of them. If it is deemed that IVF is required an individualised approach is used. With the support of her nursing, embryology and reception staff at Genea, Dr Kalra is able to help her patients achieve the best success rates possible.
Course curriculum
-
1
How to complete this course
-
Instructions
-
-
2
Carrier Screening and Medicare Rebate
-
Summary
-
Video lecture (25 mins)
-
Quiz: test your learning (10 mins)
-
-
3
Document your CPD here
-
CPD Documentation and Reflection Activity Tool
-
-
4
Feedback
-
Please let us know your thoughts
-